Lynch & Associates Cyto Dyn Inc. Transaction History
Lynch & Associates
- $467 Million
- Q3 2024
Shares
3 transactions
Others Institutions Holding CYDY
# of Institutions
10Shares Held
409KCall Options Held
0Put Options Held
0-
Eagle Bay Advisors LLC New York, NY162KShares$21,0740.01% of portfolio
-
Diversified Trust CO45.8KShares$5,9520.0% of portfolio
-
Virtue Capital Management, LLC Brentwood, TN45KShares$5,8500.0% of portfolio
-
Mai Capital Management42.5KShares$5,5220.0% of portfolio
-
Rfp Financial Group LLC Atlanta, GA41.5KShares$5,3880.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $106M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...